PRONOUNCE: Prostate Cancer Drugs and CVD
July 20, 2022 | Renato Lopes and C. Michael Gibson discuss PRONOUNCE comparing the cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and CVD. |
New at TCTMD? Register today!
Enter the email you used to register to reset your password.